Loading…

Classification for treatment urgency for the microphthalmia/anophthalmia spectrum using clinical and biometrical characteristics

Purpose Current clinical classifications do not distinguish between the severity of the MICrophthalmia/Anophthalmia (MICA) spectrum with regard to treatment urgency. We aim to provide parameters for distinguishing mild, moderate and severe MICA using clinical and biometrical characteristics. Methods...

Full description

Saved in:
Bibliographic Details
Published in:Acta ophthalmologica (Oxford, England) England), 2020-08, Vol.98 (5), p.514-520
Main Authors: Groot, Annabel L.W., Kuijten, Maayke M.P., Remmers, Jelmer, Gilani, Asra, Mourits, Daphne L., Kraal‐Biezen, Elke, Graaf, Pim, Zwijnenburg, Petra J., Moll, Annette C., Tan, Stevie, Saeed, Peerooz, Hartong, Dyonne T.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose Current clinical classifications do not distinguish between the severity of the MICrophthalmia/Anophthalmia (MICA) spectrum with regard to treatment urgency. We aim to provide parameters for distinguishing mild, moderate and severe MICA using clinical and biometrical characteristics. Methods We performed a single‐centre, cross‐sectional analysis of prospective cohort of 58 MICA children from September 2013 to February 2018 seen at the Amsterdam University Medical Center, The Netherlands. All patients with a visible underdeveloped globe were included. We performed full ophthalmic evaluation including horizontal palpebral fissure length, axial length by ultrasound and/or MRI measurements, paediatric and genetic evaluation. Cases were subdivided based on clinical characteristics. Biometrical data were used to calculate the relative axial length (rAL) and the relative horizontal palpebral fissure length (rHPF) compared with the healthy contralateral eye for unilateral cases. Results In previously untreated patients, a strong correlation exists between rAL and rHPF, distinguishing between severe, moderate and mild subjects using rAL of 0–45%, 45–75% and 75%–100%, respectively. Clinical subgroups were randomly dispersed throughout the scatterplot. Conclusion Current classifications lack clinical implications for MICA patients. We suggest measuring eyelid length and axial length to classify the severity and determine treatment strategy. The ‘severe’ group has obvious asymmetry and abnormal socket configuration for which therapy should quickly be initiated; the ‘moderately’ affected group has normal socket anatomy with a microphthalmic eye with disturbing asymmetry for which treatment should be initiated within months of development; the ‘mild’ group has a slightly smaller axial length or less obvious eyelid asymmetry for which reconstructive correction is possible, but expansive conformer treatment is unnecessary.
ISSN:1755-375X
1755-3768
DOI:10.1111/aos.14364